Sheng-Xiang Lin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 10

Top Venues

The journal of physical chemistry letters

Viruses

Journal of the American Chemical Society

Bioengineering (Basel, Switzerland)

Université Laval Faculté de médecine

Institut de Biologie Moléculaire et Cellulaire (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Laval Faculté de médecine

Canada

Full Professor

Centre hospitalier de l'Université Laval

Canada

Senior Scientist :: Laboratory of Molecular Endocrinology

Université Laval Faculté de médecine

Canada

Associate Professor

Université Laval Faculté de médecine

Canada

Assistant Professor

Université Laval Faculté de médecine

Canada

Professeur subventionnel

Université Laval Faculté des sciences et de génie

Canada

Professeur invité :: Department of Biochemistry

Case Western Reserve University

United States

Visiting Professor :: Department of Biochemistry

Institute of Biochemistry and Cell Biology

China

Associate Professor

Education History

Institut de Biologie Moléculaire et Cellulaire

France

PHD

Publications

Saleem Iqbal, Sheng-Xiang Lin
Deep Drug Discovery of Mac Domain of SARS-CoV-2 (WT) Spike Inhibitors: Using Experimental ACE2 Inhibition TR-FRET Assay, Screening, Molecular Dynamic Simulations and Free Energy Calculations. Bioengineering (Basel, Switzerland) 10 (8) (2023)
Wenfa Zhang, Sheng-Xiang Lin
Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2. Viruses 15 (2) (2023)
Wenfa Zhang, Sheng-Xiang Lin
Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2. Viruses 15 (2) (2023)
Xiaoye Sang, Nassira Belmessabih, Ruixuan Wang, Preyesh Stephen, Sheng-Xiang Lin
CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer. Cancers 14 (4) (2022)
Wen-Fa Zhang, Preyesh Stephen, Jean-François Thériault, Ruixuan Wang, Sheng-Xiang Lin
Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks. The journal of physical chemistry letters 11 (11) (2020)
Qian Ran, Yang Xiang, Preyesh Stephen, Chun Wu, Tang Li, Sheng-Xiang Lin, Zhongjun Li
CRIF1-CDK2 Interface Inhibitors: An Unprecedented Strategy for Modulation of Cell Radiosensitivity. Journal of the American Chemical Society 141 (4) (2019)
Tang Li, Preyesh Stephen, Dao-Wei Zhu, Rong Shi, Sheng-Xiang Lin
Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP+ reveal the mechanism of substrate inhibition. The FEBS journal 286 (11) (2019)
Tang Li, René Maltais, Donald Poirier, Sheng-Xiang Lin
Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide. The journal of physical chemistry letters 9 (18) (2018)
Preyesh Stephen, Sheng-Xiang Lin
RNA-dependent RNA polymerase: Addressing Zika outbreak by a phylogeny-based drug target study. Chemical biology & drug design 91 (1) (2017)
Preyesh Stephen, Mariana Baz, Guy Boivin, Sheng-Xiang Lin
Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase Inhibitors. Journal of the American Chemical Society 138 (50) (2016)

Sheng-Xiang Lin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sheng-Xiang Lin